The Business Research Company published its Biologics Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Biologics market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the biologics market’s segments-
1) By Type, Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
2) By Distribution Channel, Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration, Oral, Parenteral, Others
4) By Drug Classification, Branded Drugs, Generic Drugs
5) By Mode Of Purchase, Prescription-Based Drugs, Over-The-Counter Drugs.
Subsegments Covered: Anti-Cancer MAbS, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MABS, Cardiovascular And Cerebrovascular MAbS, Others - Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Others - Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Others-Vaccines.
View Complete Report: https://www.thebusinessresearchcompany.com/report/biologics-global-market-report-2020-30-covid-19-impact-and-recovery
Biologics Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global biologics market is expected to decline from $269.2 billion in 2019 to $239.2 billion in 2020 at a compound annual growth rate (CAGR) of -11.2%. The decline is mainly due to the worldwide supply and demand failures of drugs due to the COVID-19 outbreak. The biologic drug shortages because of an inadequate production of biologics is hampering the market growth. The inadequate or slowed production is due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing to contain the spread of virus and keep the staff safe. The market is then expected to recover and grow at a CAGR of 15% from 2021 and reach $464.7 billion in 2023.
Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, Crohn’s disease that have limited treatment options. There has been a significant advance in the treatment of rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs.
Few Points From Table Of Content
1. Executive Summary
2. Report Structure
3. Biologics Market Characteristics
4. Biologics Market Product Analysis
5. Biologics Market Supply Chain
……
21. Key Mergers And Acquisitions In The Biologics Market
22. Market Background: Pharmaceuticals Market
23. Recommendations
24. Appendix
25. Copyright And Disclaimer
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3141&type=smp
Few Points From List Of Table
Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Biologics Market, 2019, By Region, Value ($ Billion)
……..
Table 133: Global Biologics Market In 2023- Growth Countries
Table 134: Global Biologics Market In 2023- Growth Segments
Table 135: Global Biologics Market In 2023- Growth Strategies
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
